The diagnosis of dental pain that results from a pulpal pathosis may prove to be a confusing and complex issue for both dental students and experienced clinicians alike. A computerized diagnostic expert system, COMENDEX, was developed to aid in the clinical diagnosis of pulpal pathosis and to provide a rapid, accurate second opinion when a human consultant is not readily available. The vast majority of diagnostic expert systems use a single reasoning methodology as their inference mechanism. COMENDEX is a prototype hybrid expert system that combines and exploits the best aspects of both rule-based and statistical reasoning methodologies. The COMENDEX endodontic diagnostic system was tested to determine the validity and accuracy of its diagnoses by the use of a variant of Turing's test and weighted kappa statistic. The promising result obtained from the initial tests suggests that an expert system using this type of hybrid reasoning methodology is well suited to the area of endodontic diagnosis and may prove highly successful if expanded to include other problem areas in oral diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0030-4220(93)90277-b | DOI Listing |
BMC Public Health
January 2025
Department of Women & Children's Health, King's College London, London, UK.
Background: Recurrent early pregnancy loss [rEPL] is a traumatic experience, marked by feelings such as grief and depression, and often anxiety. Despite this, the psychological consequences of rEPL are often overlooked, particularly when considering future reproductive health or approaching subsequent pregnancies. The SARS-CoV-2 pandemic led to significant reconfiguration of maternity care and a negative impact on the perinatal experience, but the specific impact on women's experience of rEPL has yet to be explored.
View Article and Find Full Text PDFPituitary
January 2025
Division of Endocrinology, Santiago de Compostela University and Ciber OBN, Santiago, Spain.
Purpose: A recent update of consensus guidelines for the management of Cushing's disease (CD) included indications for medical therapy. However, there is limited evidence regarding their implementation in clinical practice. This study aimed to evaluate current medical therapy approaches by expert pituitary centers through an audit conducted to validate the criteria of Pituitary Tumors Centers of Excellence (PTCOEs) and provide an initial standard of medical care for CD.
View Article and Find Full Text PDFJ Allergy Clin Immunol
January 2025
Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai; New York, NY, USA.
Background: The 2006 National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network (NIAID/FAAN) anaphylaxis criteria are widely used in clinical care and research. In 2020, the World Allergy Organization (WAO) published modified criteria that have not been uniformly adopted. Different criteria contribute to inconsistent care and research outcomes.
View Article and Find Full Text PDFPhilos Trans A Math Phys Eng Sci
January 2025
Air Force Research Laboratory 711th Human Performance Wing, Wright-Patterson AFB, OH, USA.
We adopt a tripart approach in describing the human-centred challenges with human-swarm interaction. First, the results of large-N laboratory studies will be discussed which found evidence of trust biases (e.g.
View Article and Find Full Text PDFDatabase (Oxford)
January 2025
Research and Development Centre, Agriculture and Agri-Food Canada, 960 Carling Avenue, Ottawa, ON CA K1A 0C6, Canada.
It is well-known that the use of vocabulary in phenotype treatments is often inconsistent. An earlier survey of biologists who create or use phenotypic characters revealed that this lack of standardization leads to ambiguities, frustrating both the consumers and producers of phenotypic data. Such ambiguities are challenging for biologists, and more so for Artificial Intelligence, to resolve.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!